[ad_1]
“Of course, we will initially receive certain limited-dose shipments, but this will be the case in all European Union countries simply according to population,” S. Krėpšta said at a press conference after meeting with researchers from the Council of Experts. in health.
Simon Cold
According to him, the Minister of Health Arūnas Dulkis named the first 10 thousand. Sending doses may not seem large, especially considering that a person will need to be vaccinated twice, but this can still become a serious challenge to vaccinate people quickly and effectively.
“It may be necessary to vaccinate a thousand people every day, and perhaps the most important thing is to be prepared from the logistical and managerial side so that there are no interruptions and the public receives all the information,” said the president’s adviser.
He recalled that shortly after the vaccine developed by BioNTech and Pfizer was authorized in late December, a second Moderna vaccine could be approved in January.
According to the Council of Experts of the Presidency, it is necessary to address the logistical challenges to ensure a smooth vaccination, since the first vaccines must be stored at extremely low temperatures.
It is also necessary to publish clear criteria on when and whose turn it will be to get vaccinated. Under foreign practice, vaccinating doctors working with COVID-19 patients and the elderly with chronic illnesses should be vaccinated first.
Last but not least, according to experts and the Presidency, designate a clear body to coordinate vaccination throughout the country, provide methodological information to treatment facilities, inform the public about the benefits of the vaccine, and report the effects secondary in a transparent way.
“A draft communication plan for health experts has been prepared and will be presented today to the Government and the Ministry of Health,” said S. Krėpšta.
Krėpšta emphasized that the European Union has concluded agreements with a total of six potential vaccine suppliers, therefore, according to him, Lithuania will have “sufficient availability of vaccines” next year if they are approved as safe and effective.
[ad_2]
